Baudax Bio Stock

Baudax Bio Net Margin

Delisted

The Net Profit Margin of Baudax Bio (BXRX) as of Jul 26, 2026 is -563.75 %. In the previous year, Net Profit Margin was -4,633.18 % — a change of -87.83% (higher).

Net Margin

-563.75 %

YoY

-87.83%

Last updated:

Net Profit Margin of Baudax Bio is 2026 -563.75 % . Net Profit Margin of Baudax Bio was 2025 -4,633.18 % . It decreases by -87.83% higher compared to the previous year.

For Baudax Bio, the net margin of -563.8% is up versus -5,158.5% a few years ago.

Access this data via the Eulerpool API

Baudax Bio Stock analysis

What does Baudax Bio do? Baudax Bio Inc is a leading biotechnology company that provides innovative products and solutions to improve human health. The company was founded in 2019 and is headquartered in Malvern, Pennsylvania. It is listed on the NASDAQ Capital Market. Baudax Bio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Baudax Bio stock

Net Profit Margin of Baudax Bio is -563.75 % in 2026.

Access this data via the Eulerpool API

Margins — Baudax Bio

All Key Metrics — Baudax Bio